[1]
“CARDIOMETABOLIC RISK PREDICTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH SUBCLINICAL HYPOTHYROIDISM”, IAPGOS, vol. 13, no. 2, pp. 64–68, Jun. 2023, doi: 10.35784/iapgos.3654.